Top

Current Atherosclerosis Reports

Content (6 Articles)

Review

European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

Angela Pirillo, Lale Tokgözoğlu, Alberico L. Catapano

Open Access Hypercholesterolemia Review

Gene Editing for the Treatment of Hypercholesterolemia

Menno Hoekstra, Miranda Van Eck

PCSK9 Inhibitor Review

Oral PCSK9 Inhibitors

Anandita Agarwala, Ramsha Asim, Christie M. Ballantyne

Review

The Role of Genetics in Advancing Cardiometabolic Drug Development

Roukoz Abou-Karam, Fangzhou Cheng, Shoshana Gady, Akl C. Fahed

Open Access Arterial Occlusive Disease Review

The Effects of FABP4 on Cardiovascular Disease in the Aging Population

Ellen M. van der Ark-Vonk, Mike V. Puijk, Gerard Pasterkamp, Sander W. van der Laan

Heart Failure Review

Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials

Cosimo Andrea Stamerra, Paolo Di Giosia, Paolo Giorgini, Tannaz Jamialahmadi, Amirhossein Sahebkar

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.